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Paper
Likelihood of aneurysmal subarachnoid 
haemorrhage in patients with normal unenhanced 
CT, CSF xanthochromia on spectrophotometry 
and negative CT angiography  
ABSTRACT 
Background: Patients with suspected subarachnoid haemorrhage, a normal non-
contrast computed tomography (CT) and cerebrospinal fluid (CSF) evidence of 
haemoglobin breakdown products often undergo CT angiography (CTA). If this is 
normal, then invasive catheter angiography may be offered. In current clinical 
practice, haemoglobin breakdown products are detected by spectrophotometry 
rather than visible xanthochromia, and CTA is performed on multidetector 
scanners. The aim of this study was to determine if such patients should still have 
a catheter angiography, given the associated risks.
Methods: Patients positive for CSF spectrophotometry (n=26) were 
retrospectively identified from the clinical biochemistry information system and 
imaging data from the electronic radiology records were reviewed. Discharge 
letters were consulted to relate the biochemistry and radiology results to the 
final diagnosis. 
Results: 15 patients with CT angiography were found. Nine patients had normal 
CT angiography. No causative aneurysms had been missed. One patient had small, 
coincidental aneurysms missed on initial reading of the CTA.
Conclusion: The likelihood of a clinically significant aneurysm in a patient who is 
CT negative, lumbar puncture positive and CTA negative is low. Double reporting 
of negative CT angiograms may be advisable.
KeywoRdS Angiogram-negative subarachnoid haemorrhage, spectrophotometry, 
subarachnoid haemorrhage, xanthochromia
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BACKgRound
Subarachnoid haemorrhage (SAH) is a rare, potentially 
fatal cause of headache. Classically, the patient will 
present with a sudden onset, severe headache and 
meningeal signs and/or altered consciousness. One 
important and treatable cause of SAH is an underlying, 
contained, ruptured cerebral berry aneurysm. These 
berry aneurysms require treatment to prevent recurrent 
SAH, because further bleeds can be more substantial, 
more disabling, potentially untreatable and fatal.1,2
The initial investigation for clinically suspected SAH is 
unenhanced computed tomography (CT). This has a 
sensitivity of 91–98% which decreases with time from 
onset of symptoms.3,4 In many institutions, if SAH is 
detected on CT, then CT angiography (CTA) is the next 
line investigation to identify and characterise berry 
aneurysms with a view to treatment.
Lumbar puncture (LP) is performed in those in whom 
SAH is suspected clinically but who have normal 
unenhanced CT results.5 Subarachnoid blood is broken 
down into bilirubin, which produces a visible yellow 
discolouration of cerebrospinal fluid (CSF) known as 
xanthochromia. This is measured with high sensitivity 
using spectrophotometry.6 Patients found to have CSF 
evidence of SAH often undergo CTA with a view to 
defining size, number and potential treatability of the 
berry aneurysms.
Not all patients with CSF xanthochromia have 
aneurysms;7 and it is not proven that patients with a 
positive LP, normal unenhanced CT and normal CTA 
require further catheter angiographic follow-up. Patients 
who have been followed up by catheter angiography are 
sometimes reported as subsets of larger studies. 
Kershenovich et al.8 reported eight patients followed up 
by catheter angiography. Westerlaan et al.9 reported 13 
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patients, of whom 12 were followed up with digital 
subtraction angiography (DSA) and one with repeat 
CTA.  Agid et al.10 followed up 32 patients and found one 
case of vasculitis on DSA, which was retrospectively 
visible on CTA. Similarly, others reported 16 patients,11 
two patients12 and 27 patients.13 Thus no aneurysms 
were identified in a total of 98 patients. No studies were 
found in which CT and CTA negative but CSF positive 
patients were the sole subject of investigation.
Catheter angiography is regarded as a gold standard. 
However, it has a risk of neurological and other 
complications.  A report on 2,899 patients between 1996 
and 200114 noted a 1.3% risk of neurological complications 
and a 0.5% risk of permanent neurological complications. 
Fifi et al.15 reported no neurological complications in 
3,636 patients who had diagnostic angiograms performed 
only by interventional neuroradiologists in an academic 
centre. These high-volume centres, performing 
approximately 500 procedures per year, gain experience 
which is not achievable in less densely populated areas; 
and experience is decreasing as noninvasive vascular 
imaging improves. Clinically undetectable brain ischaemia 
may be revealed by diffusion-weighted imaging in 11–26% 
of patients undergoing diagnostic cerebral angiography.16–9 
Although the clinical significance of such ‘silent’ ischaemic 
lesions is debated, there is evidence that the cumulative 
burden of ischaemic lesions results in neuropsychological 
deficits or vascular dementia.20
The study by Fifi et al. identified one femoral abscess, two 
femoral occlusions with leg ischaemia requiring surgical 
revascularisation, one dissecting pseudo-aneurysm 
requiring thrombin injection and one retroperitoneal 
haematoma requiring transfusion,15 emphasising that 
non-neurological complications may be serious.
Given the risks of catheter angiography and uncertainty 
as to whether it is necessary in the sub-group of patients 
with normal unenhanced CT and CTA, but positive CSF 
spectrophotometry, we aimed to determine if this group 
of patients still warrants the risk of catheter angiography 
in the context of modern CT imaging.
MeThodS
The institutional ethics committee considered that this 
retrospective study was a clinical audit and therefore did 
not require ethical approval. However, the departmental 
data protection officer advised that all patient data 
should be fully anonymised.
A search of the clinical biochemistry laboratory 
information system (APEX, iSOFT plc, Banbury, UK) 
yielded data on all CSF samples positive for haemoglobin 
breakdown products (analysed using the UvikonXL 
spectrophotometer, Northstar Scientific, Leeds, UK). 
Analysis and reporting were performed in accordance 
with the UK National External Quality Assessment 
Service (NEQAS) national guidelines. Net bilirubin 
absorbance was measured at 476 nm; an absorbance of 
≤0.007 AU indicated that bilirubin was not raised. 
Likewise, a net oxyhaemoglobin absorbance of ≤0.02 AU 
indicated that oxyhaemoglobin was not raised.6
 
Patients who had positive spectrophotometry were 
individually searched on the radiology information 
system. All images and reports were reviewed, as were 
the electronic discharge summaries for CTA negative 
patients.  The majority of CT angiograms were performed 
in Aberdeen Royal Infirmary using a 128-multidetector 
Siemens Definition (Erlangen, Germany) scanner. A 
minority of CT angiograms were performed in hospitals 
with 64-multidetector Toshiba Aquilion (Tokyo, Japan) 
and on 40-multidetector Philips Brilliance (Best, 
Netherlands) scanners.
Patients were excluded if there was a known 
haemorrhage on unenhanced CT or if neurovascular 
imaging had not been performed. For the purposes of 
this study, patients with insufficient CSF samples or in 
whom oxyhaemoglobin levels impaired ability to detect 
bilirubin were not regarded as LP positive.
ReSulTS
A total of 316 CSF samples were analysed by 
spectrophotometry between 1 February 2011 and 31 
January 2012. There were 26 patients with bilirubin 
detected by spectrophotometry which was not 
accounted for by increased serum bilirubin. Figure 1 
shows a breakdown of the samples included in this study. 
The excluded patients with known haemorrhage 
included one post-neurosurgical patient who was being 
investigated for meningitis, one patient with known 
contusions who was being investigated for meningitis, 
one pregnant patient with intracerebral haemorrhages 
secondary to eclampsia and one patient with a 
perimesencephalic haemorrhage (the latter patient had 
CTA performed). One patient with encephalitis and one 
patient with malignant meningitis secondary to breast 
cancer had no vascular imaging performed. In five 
patients the reason for not proceeding to vascular 
imaging was unclear. Of the remaining 15 patients, six 
had aneurysms detected by the radiologist on the first 
CT angiogram. This left nine patients with a negative 
unenhanced CT, positive CSF spectrophotometry and an 
apparently normal first CT angiogram. These are 
presented in Table 1. All but two of the patients were 
imaged in Aberdeen Royal Infirmary.
One 75-year-old patient did have aneurysms missed on 
CT cerebral angiography which were identified on a 
Spectrophotometry positive CTA negative subarachnoid haemorrhage
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later noninvasive CT angiogram of the neck. These 
aneurysms were retrospectively visible on the initial CT 
cerebral angiography (Figure 2). The sac diameters were 
2 mm and 3 mm, and they were deemed not to be 
causative after multi-disciplinary review. This patient was 
also imaged on the 128-multidetector CT scanner.
Case referral comments Lumbar puncture comments 
(biochemistry laboratory 
comments are in quotation marks)
Radiological follow-up/outcome
1 History of depression. Patient 
intermittently confused. Referrer was 
suspecting encephalitis.
‘Bilirubin and oxyhaemoglobin increased. 
Consistent with SAH.’
CTA negative. No further vascular 
imaging. Discharge diagnosis: 
psychogenic headache. Patient alive 28 
months later.
2 Known alcoholism, disproportionate 
cerebellar atrophy.
‘Bilirubin and oxyhaemoglobin increased. 
Consistent with SAH.’
Normal CTA. Discharge diagnosis: 
tension type headache. Patient alive 20 
months later.
3 50-year-old female with three-
day history of gradual onset frontal 
headache. Headaches unusual for 
this patient and worsening despite 
medication. 
Eight unsuccessful attempts at LP, 
eventually successful under radiological 
guidance. Bloodstained CSF.  ‘Bilirubin 
and oxyhaemoglobin increased. 
Consistent with SAH.’
One CTA normal. No further imaging 
follow-up. History considered not 
typical for SAH and the final diagnosis 
was prolonged migraine.
4 Had presented two days earlier with 
sudden onset occipital headache and 
nausea.
‘Bilirubin and oxyhaemoglobin increased. 
Consistent with SAH. Sample not 
protected from light, interpret results 
with caution due to possible bilirubin 
degradation.’
Patient returned overseas. Discharge 
diagnosis: presumed perimesencephalic 
haemorrhage.
5 50-year-old male with diabetes, 
retinopathy, hypertension and ischaemic 
heart disease. Ten days before admission  
had thunderclap headache and 
vomiting 4–5 hours duration, preceded 
by sweating, dizziness and blurred 
vision. Dizziness and unsteadiness 
on examination. Non-smoker and no 
alcohol use. 
‘Increased CSF bilirubin. This finding may 
be consistent with SAH, an increased 
bilirubin accompanying the increased 
CSF protein, or other source of CSF 
blood.’ Persistently raised bilirubin and 
protein on LP one month later. No red 
cells, white cells organisms or growth 
on either occasion.
Normal CT angiogram and normal 
catheter angiogram. Symptoms 
gradually improved. Later whole spine 
MRI showed minor degenerative 
changes and high T1 signal in a thoracic 
intervertebral disc. No final diagnosis 
for the headache, speculated post-viral 
inflammation. Alive 28 months later.
6 30-year-old male with sudden onset 
headache nine days before admission. 
On citalopram for depression. 
Difficult LP successful after multiple 
failed attempts. Bruise on back. 
‘Increased CSF bilirubin. Consistent with 
SAH.’ Red cell count 2/µL.
CTA normal. Final diagnosis migraine + 
post-LP headache.  Alive seven months 
later. 
7 50-year-old female with sudden 
onset worst headache ever, nausea, 
posterior head pain and photophobia. 
No neurological signs. 
‘Increased CSF bilirubin. Consistent with 
SAH. Sample bloodstained – interpret 
results with caution.’
CTA and DSA normal. Later diagnosed 
as migraine and remains under 
neurology follow up. Alive 28 months 
later.
8 75-year-old female with previous 
stroke presenting with bifrontal 
headache, nausea and vomiting. 
‘Increased CSF bilirubin. Consistent with 
SAH.’
Missed aneurysm on initial CTA, 
identified on neck CTA eight days later. 
Left carotid 3 mm and 2 mm aneurysms 
(Figure 2). No additional treatment 
or imaging follow-up due to location 
of aneurysm possibly being incidental 
to her symptoms and patient co-
morbidities. Alive 22 months later.
9 Thunderclap headache and one bout 
of vomiting five days before admission. 
No neurological signs.
‘Increased CSF bilirubin. Consistent with 
SAH.’
CTA, DSA and MRA follow-up negative. 
Alive 18 months later.
CSF= cerebrospinal fluid; CTA= computed tomography angiography; DSA= digital subtraction angiography; LP= lumbar 
puncture; SAH= subarachnoid haemorrhage.
TABLe 1 Unenhanced CT negative, LP positive and CTA negative patients. To maintain patient anonymity, patient ages have 
been altered to the nearest five years where given
AK Rana, HE Turner, KA Deans
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diSCuSSion
In our sample of 15 LP positive patients with CT 
angiography available, six patients had aneurysms detected 
on the initial CTA and all six subsequently underwent 
treatment. This gives positive spectrophotometry a 
positive predictive value (PPV) of 40% for aneurysms 
warranting treatment. This compares with PPVs of 72% 
for visual inspection (but with poor sensitivity),7,22 19% for 
the Leiden method,23 or 3% for xanthochromic index.24
Our cases confirm that positive CSF spectrophotometry 
occurs in haemorrhagic conditions such as contusions, 
recent neurosurgery, difficult traumatic LP, peri-
mesencephalic haemorrhage and also in other conditions 
such as encephalitis and malignant meningitis. In a study 
using DSA,25 the clinical diagnoses in those without 
aneurysms were traumatic SAH, sickle-cell disease, HIV 
positive with varicella, migraine and systemic lupus 
erythematosus plus antiphospholipid syndrome. In a 
significant proportion of cases the cause of haemoglobin 
breakdown products was not identified;25 however, the 
outcome was favourable in these patients.26 Our patients 
who had spectrophotometric evidence of xanthochromia 
and no vascular imaging suggest that CSF biochemistry 
was performed when not required or that a diagnosis 
other than SAH was regarded as more likely.
Initial angiography by invasive DSA was not the subject 
of this study. There are several such studies in patients 
with no abnormality on CT, and LP-diagnosed 
haemorrhage. Rinkel et al.28 reported three patients who 
did well on clinical follow-up. Jung et al.29 reported 12 
patients, all of whom had no significant resultant 
disability; also, no abnormality was found in the one 
patient who had a second catheter angiogram.  Topcuoglu 
et al.26 did not find the cause of haemorrhage in nine 
patients. Almandoz et al.30 reported five CSF 
xanthochromia patients who had a negative initial 
catheter angiogram and no causative aneurysm on 
follow-up CTA and magnetic resonance angiography 
(MRA). Our study focused on the use of CTA as the 
initial vascular imaging. In cases where SAH is conspicuous 
on unenhanced CT, it is already known that aneurysms 
may be missed on CTA if they are small, or if they are 
multiple aneurysms,31 close to bone,11 or due to arterial 
spasm.10 Where SAH is not visible on unenhanced CT, 
this limitation of CTA seemed not to apply.10,11
Agid et al.10 and Kelliny et al.11 concluded that CTA 
without confirmatory catheter angiography (DSA) may 
be sufficient to exclude ruptured aneurysms for patients 
without any haemorrhage on plain CT. The strategy of 
avoiding DSA is gaining acceptance in perimesencephalic 
SAH,8,10,11 and a similar change may occur in CT negative, 
LP positive and CTA negative patients. The enthusiasm 
for invasive vascular imaging varies between clinicians, 
units and countries and is also changing over time as the 
quality of noninvasive vascular imaging improves.
316 samples
26 patients positive CSF bilirubin
15 patients positive CSF and CTA 
available
9 patients apparently CTA 
negative
6 aneurysms found on initial CTA, all subsequently clipped or coiled
11 patients haemorrhage reported on CT or no vascular imaging
275 bilirubin not increased
5 oxyhaemoglobin present in sufficient quantity to impair ability to  
detect bilirubin
4 samples insufficient for analysis
4 increased CSF bilirubin probably accounted for by increase in  
serum bilirubin
1 patient with 2 LPs
1 national control sample
3 DSA – no aneurysm or AVM
5 no further arterial imaging
1 incidental cavernous carotid aneurysm found on carotid CTA
FiguRe 1 Outline of the retrospective audit. 
SAH= subarachnoid haemorrhage  
CTA= computed tomography angiography  
DSA= digital subtraction angiography  
CSF= cerebrospinal fluid  
LP= lumbar puncture
AVM= arteriovenous malformation
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In one of our patients two very small aneurysms were 
missed on initial reading by the radiologist on the CT 
angiogram. These aneurysms, considered to be incidental, 
were not treated (Figure 2).
Intracavernous aneurysms generally exhibit a benign clinical 
course. Rupture leads to carotido-cavernous fistulae and 
rarely, SAH.32,33 The ones treated in the van Rooij study had a 
mean size of 10 mm if treated by coil embolisation, 21 mm if 
treated by occlusion and 27 mm if treated by bypass.33 This 
compares to 2 mm in our case.
The paraclinoid location is common in patients with 
unruptured intracranial aneurysms. However, they represent 
only 1.4–9.1% of patients with ruptured aneurysms.27 The 
patients with SAH treated by Loumiotis et al. had aneurysms 
with a mean fundus size of 8 mm, 79% of which were less 
than 10 mm.27 This compares with 3 mm in our case.
Aneurysms close to bone have a known risk of being missed. 
Our case resembles the cases published by Kelliny et al.11 and 
Agid et al.10 Those cases were in the context of CT visible 
SAH, whereas our case differs in the context of no 
haemorrhage visible on CT.
Measures to detect aneurysms in apparently negative CTA 
cases include double reporting of CT angiograms, DSA, 
repeat CT angiography and follow-up MRA.
FiguRe 2 Missed aneurysms on CT angiography. The internal carotid artery segments are labelled according to the 
embryonic segments described by Lasjaunias and Santoyo-Vazquez and updated by Gailloud et al.36 The ascending cavernous 
aneurysm measures 2 x 2 mm and the clinoid aneurysm measures 5 x 3 mm. 
AK Rana, HE Turner, KA Deans
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Review of our false-negative CT shows that the aneurysms 
were visible on the initial CTA. Double-reporting of 
‘normal’ CT angiograms may therefore detect the 
oversight, a strategy that would require no additional 
patient attendances. This depends on the second 
radiologist being attuned to the likely sites of missed 
aneurysms. Invasive angiography would also have 
detected these aneurysms. However, as our patient did 
not require treatment it is inappropriate to recommend 
DSA, with its attendant risks.
Magnetic resonance angiography is a possible noninvasive 
follow-up modality. Like DSA, it does not have the 
difficulty of distinguishing aneurysm from bone, but 
unlike DSA there is no risk of vascular injury.
Digital subtraction angiography is regarded as the gold 
standard for excluding vascular pathologies, and avoiding 
DSA may have disadvantages. DSA may allow vasculitis to 
be shown as found by Agid et al.10 and the sequential 
images demonstrate abnormal flow through arterio-
venous malformations (although a delayed repeat DSA 
may be required to show a small lesion34).  Another 
consequence of avoiding DSA is that experience of the 
procedure may be insufficient to maintain operator 
competence.
Where does the balance lie between the risk of DSA 
(and its cost) and that of missing a significant berry 
aneurysm? The number of patients studied here and 
elsewhere remains small, limiting any firm conclusions. 
Others have suggested that, in perimesencephalic 
haemorrhage, CT angiography alone is the best diagnostic 
strategy.35 However, this is not yet agreed practice in CT 
normal suspected SAH.
liMiTATionS of ThiS STudy
Our review is limited by the small number of patients 
found to be CT negative, LP positive and CTA negative, 
reflecting the rarity of this clinical scenario which has, in 
turn, led to the small numbers of patient cases published 
elsewhere. Our study does not consider other potential 
causes of occult SAH such as vasculitis or reversible 
cerebral vasoconstriction syndrome. Only three of our 
nine patients had DSA and this may reflect a change in 
practice away from DSA. Furthermore, the retrospective 
nature of this review and clinical review limited to 
discharge letters meant that the study of clinical 
information on individual patients was limited. A larger, 
collaborative, multi-disciplinary, prospective study would 
benefit our understanding of this type of occult SAH.
ConCluSion
The risk of missing a clinically significant aneurysm is low 
in patients with a normal unenhanced CT, CSF 
spectrophotometry positive for haemoglobin break-
down products and a negative CTA. 
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